All topics
From research to finished goods
Product briefs, samples, ingredients and packaging, pilots, release testing, packaging and delivery require clear ownership. FD1 can ask a lead contractor to coordinate, but owned and subcontracted steps and acceptance criteria need written confirmation.
In-depth articles
All articles →A map of related concepts; see the entries and sources for detail.
Reference entries
Five gates from paper to productProject inference
Plausible mechanism → human benefit → matching ingredient and dose → effective, tolerated finished formula → verified quality and sales route. Missing a gate weakens the claim.
This is our research framework, not a universal statutory launch sequence.
Validate the actual use caseProject inference
Check tolerance, adherence and specifications, then test a prespecified primary outcome using the final formula, audience and actual regimen, reporting null results too.
FD1’s next knowledge gapsProject inference
Priorities are actual dietary gaps in the Chinese target group, one lead benefit, matching specifications and doses, formula tolerance and stability, and market eligibility.
Lead contractor and subcontractingProject inference
Turnkey describes project responsibility; it does not imply one factory owns every operation. Obtain written steps, sites, subcontracting, quality release and delivery boundaries.
Samples, pilot and commercial productionProject inference
Development samples help assess taste and feasibility, but do not automatically establish commercial-batch uniformity, shelf life or market eligibility. Verification is needed under applicable process and packaging conditions.
Formula ownership, changes and transferProject inference
Beyond price, define ownership of formula and technical records, approval of ingredient or site changes, exclusivity, transfer feasibility and quality responsibilities.